Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with the disease worldwide. As MS is an ...
B-cell depletion therapies, in which B cells of the immune system that may drive disease activity in multiple sclerosis (MS) ...
An international study has used a computational biology tool that, by analyzing a multitude of biological data from multiple sclerosis patients ranging from genetic information to the whole organism, ...
Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...
Add Yahoo as a preferred source to see more of our stories on Google. Brain inflammation may be fueled by a gene on the X chromosome, a new study in mice suggests. And in female mice, who carry two X ...
The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...
MONDAY, Nov. 10, 2025 (HealthDay News) — Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results